ICSR is a program of the Center for Health and Safety Research at the University of Wisconsin-Madison. The goal of ICSR is to develop a pharmacovigilance database that allows the public to access information about pharmaceutical drugs and the people who take them. The database will be open to the public and will contain information on the adverse drug reactions caused by the drugs.
The idea of a database of adverse drug reactions sounds scary and intimidating to the uninitiated, but ICSR is actually a pretty straightforward process. You have to fill out a few forms and send them to a computer in Madison. The computer then processes the information and sends it to a database in Washington, DC. In the next step, the database goes into maintenance mode and then searches for the drugs that cause the adverse drug reactions.
The idea of pharmacovigilance (pharmacovigilance is a term that describes how a company looks at adverse drug reactions) is to identify a drug that has caused a patient to develop an adverse drug reaction. It’s basically the same process as in the “real” world, except it’s done through a computer instead of a doctor.
I think the term that is mostly used is “clinical pharmacovigilance.” Like any technology, there is a lot of hype around a lot of things. Drugs are one of those things that is over hyped up and over hyped down. I’ve seen a number of articles that say that one of the reasons pharmaceutical companies are doing so well is because adverse drug reactions are a huge part of their business.
So if your pharmacist prescribes you a medication, you should assume it is safe unless you know otherwise. In the case of an adverse drug reaction, this means the drug isn’t safe for you. This is where I think pharmacovigilance comes into play. It’s a term that was basically coined in the early 90s to describe the process of reporting suspected adverse drug reactions to the FDA.
In the early 2000s, pharma was a company struggling financially, so they didn’t do so well at all. This led to drug companies being forced to do things like go deeper into the drug’s ingredients and manufacturing details to ensure the drug is safe to use. Pharmacovigilance is the process of looking at adverse-drug-reaction reports and finding out if it has been reported in the past and whether it’s been recorded properly.
The idea behind pharmacovigilance is that the public has a right to know if their drug or medication is unsafe and it gives them the ability to monitor what is going on with their medication and how their medication is being taken. It’s a great way to ensure your patients are receiving the quality medication they need. Unfortunately, due to the fact that pharma was forced to go into more details about how their products are manufactured, the FDA’s pharmacovigilance process was slowed down.
As a pharmacist I can tell you that pharmacovigilance is always a very important process to go through. Its one of the most important processes in the medical industry. And with big pharma spending so much money to go into the shadows and get their products on store shelves, it’s absolutely necessary that the public have some way of knowing what their drugs are doing, and how they are being taken.
I’ll get to the pharmacovigilance here in a bit, but I’ll start with a very important point. If you go and click on the links below, you’ll see a list of companies that have gone through the process of making their drugs and making them available for public consumption. I’ll give you a quick summary of what these companies did, and I’m sure most of you would agree that these changes made this process far more efficient.
But in addition to making their drugs safer, these companies also made it easier and less expensive for scientists to determine which drugs were safe and which were unsafe. Imagine if all of those who donated their blood to the drug companies could see what drugs they were taking and they knew if those drugs were safe or not. Now imagine how much safer it would be if you could actually get the information from the companies themselves.